Alkyl Amines Chemicals Limited's Board of Directors approved the audited financial results for the quarter and financial year ended March 31, 2026. The board recommended a final dividend of ₹10 per equity share of ₹2 each (500%) for FY26, subject to shareholder approval. The company reported revenue from operations of ₹386.91 crores for Q4 FY26, compared to ₹386.05 crores in Q4 FY25. For the full year FY26, revenue stood at ₹1,535.85 crores against ₹1,571.82 crores in FY25. Net profit for the year was ₹180.00 crores, slightly lower than ₹186.11 crores in the previous year.

Q4 FY26 and Full-Year Financial Performance

On an operating profitability basis, Q4 EBITDA improved to 707M rupees from 682M rupees in Q4 FY25, with the EBITDA margin expanding to 18.30% from 17.67% year-on-year. The following table summarises the key financial metrics:

Management Commentary and Outlook

During the earnings conference call, management expressed cautious optimism for the coming year, expecting volume growth between 5% and 10% and better margins compared to the previous year. They noted that Chinese competition has become less aggressive, which may help restore margins. Regarding capacity, the company stated that plants are running at 60% to 85% utilization, and there is sufficient capacity for ethylamines for the next 4 to 5 years. However, the methylamines segment faces overcapacity due to a new entrant. The company also mentioned that a new product project at Dahej is slightly delayed and is expected to be commissioned by July.

Operational Updates and Guidance

Management addressed the challenges faced during the year, noting that both top-line and bottom-line growth remained flat. The company faced sourcing issues with ammonia in March due to geopolitical tensions, which led to a rise in raw material prices from around INR50 a kg to over INR100 a kg. However, the company managed to pass on these cost increases to customers, protecting margins. For FY27, the planned capex is expected to be around INR80 crores to INR90 crores, primarily for the Dahej project and engineering works.

Alkyl Amines Chemicals has received a maintained Accumulate rating from Elara Capital, with the brokerage setting a target price of ₹21,927. The rating reflects a measured outlook, acknowledging both near-term positives and structural headwinds that are expected to temper the pace of earnings recovery.

Key Drivers Behind the Rating

Elara Capital points to several factors underpinning the Accumulate stance on Alkyl Amines Chemicals. The stock's recent outperformance has been attributed to effective price pass-through mechanisms and the ramp-up of specialty products, which have supported revenue momentum. The brokerage also notes stable performance in Q4FY26 as a constructive indicator of operational resilience.

The following table summarises the key parameters highlighted by Elara Capital in its assessment:

Segment-Level Dynamics

Within the business, the acetonitrile segment stands out as a recovery story, benefiting from easing import pressures from China. This development has provided a degree of pricing and volume relief in the segment. Ethylamines, meanwhile, continue to exhibit stable dynamics, offering a steady contribution to the overall business mix.

In contrast, the methylamines segment remains weighed down by overcapacity conditions, which are constraining pricing power and limiting the scope for meaningful margin expansion across the portfolio. These structural imbalances are central to Elara Capital's view that FY27 will function as a consolidation phase for the company.

Outlook: Gradual Recovery, Not a Full-Cycle Upturn

Elara Capital's assessment underscores that while select segments are showing improvement, the combination of methylamines overcapacity, limited margin expansion potential, and the consolidation nature of FY27 means that earnings recovery is expected to be gradual. The brokerage does not anticipate a full-cycle upturn in the near term, positioning the Accumulate rating as reflective of measured optimism rather than a strong re-rating catalyst.